Showing results (461-470 of 1,433) with videos related to
Sort By:
Pageof 144
Cancer Research|February 2, 1999
Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletionsN Puget, D Stoppa-Lyonnet, O M Sinilnikova, et al.Molecular Carcinogenesis|February 1, 1996
Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell linesL Huang, D Lang, J Geradts, et al.Clinical Genetics|August 8, 2009
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsH T Lynch, P M Lynch, S J Lanspa, et al.Diseases of the Colon and Rectum|April 1, 1978
Multiple primary cancers and prolonged survival: familial colonic and endometrial cancersH T Lynch, W A Bardawil, R E Harris, et al.Digestive Diseases and Sciences|November 21, 2001
Familial adenomatous polyposis and extracolonic cancerH T Lynch, A G Thorson, R D McComb, et al.American Journal of Human Genetics|November 7, 2000
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counselingA Liede, K Metcalfe, D Hanna, et al.Cancer Genetics and Cytogenetics|February 15, 1985
Hereditary nonpolyposis colorectal cancer in a Navajo Indian familyH T Lynch, T J Drouhard, G S Schuelke, et al.European Journal of Biochemistry|September 1, 1999
Evidence that phospholipase C-gamma2 interacts with SLP-76, Syk, Lyn, LAT and the Fc receptor gamma-chain after stimulation of the collagen receptor glycoprotein VI in human plateletsB S Gross, S K Melford, S P WatsonOphthalmology|November 1, 1996
Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study GroupsC B Camras, A Alm, P Watson, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1981
Positional vertigo and nystagmus of central originP Watson, H O Barber, J Deck, et al.Pageof 144